Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)
Clinical trial NCT00092404 · COMPLETED
Trial details
- NCT number
- NCT00092404
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2005-06-01
- Enrollment
- 1210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.